tacrolimus 0.5 MG Oral Capsule
- RxCUI
- 313190
- RxNorm name
- tacrolimus 0.5 MG Oral Capsule
- Display name
- tacrolimus 0.5 MG Oral Capsule
- Full name
- tacrolimus 0.5 MG Oral Capsule
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:27
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tacrolimus | TACROLIMUS | Stellon Biotech Inc. | 6b89e8a4-9f11-42e3-8e79-fe617e7c461f | 2026-07-17 | Boxed warning, Warnings, Adverse reactions | 313190 |
| tacrolimus | TACROLIMUS | NORTHSTAR RX LLC | 875f4962-557e-4e12-ad7b-cb5fb6f2a65f | 2026-06-04 | Boxed warning, Warnings, Adverse reactions | 313190 |
| Tacrolimus | TACROLIMUS | Major Pharmaceuticals | 0addf3f5-9bd5-4ef3-8c7f-52be20c16cf9 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 313190 |
| Tacrolimus | TACROLIMUS | Safecor Health LLC | 393cd10e-133c-4d6b-b024-270eb82edbb3 | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | 313190 |
| Tacrolimus | TACROLIMUS | Jubilant Cadista Pharmaceuticals Inc. | 651bd506-96b0-43e5-a4dd-db03bf9154c9 | 2026-03-16 | Boxed warning, Warnings, Adverse reactions | 313190 |
| tacrolimus | TACROLIMUS | Glenmark Pharmaceuticals Inc., USA | 4b310c6b-e035-4e44-9573-4001d58b2ad5 | 2026-01-21 | Boxed warning, Warnings, Adverse reactions | 313190 |
| Tacrolimus | TACROLIMUS | BPI Labs LLC | 3e8bc65e-8048-4073-8e45-570330603000 | 2026-01-06 | Boxed warning, Warnings, Adverse reactions | 313190 |
| Tacrolimus | TACROLIMUS | Ajenat Pharmaceuticals LLC | ca08d4aa-3de2-4a9d-9554-6288e5d36f29 | 2025-12-29 | Boxed warning, Warnings, Adverse reactions | 313190 |
| Tacrolimus | TACROLIMUS | Ascend Laboratories, LLC | 55467f4b-8437-43a3-b6d9-1bc2a13b4c11 | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | 313190 |
| Tacrolimus | TACROLIMUS | Golden State Medical Supply, Inc. | 34ec4989-6933-4237-ae1e-50a0cb90a2fe | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | 313190 |
| Tacrolimus | TACROLIMUS | Sandoz Inc. | 46ac55cf-d85e-4c34-bb33-f49e078c4a03 | 2025-08-30 | Boxed warning, Warnings, Adverse reactions | 313190 |
| Tacrolimus | TACROLIMUS | Bryant Ranch Prepack | a2e55495-10cc-4f6e-b866-1e7d6e45888b | 2025-08-25 | Boxed warning, Warnings, Adverse reactions | 313190 |
| Tacrolimus | TACROLIMUS | Mylan Pharmaceuticals Inc. | 45af3eda-caaa-4478-9372-95aa65adc9b3 | 2025-08-15 | Boxed warning, Warnings, Adverse reactions | 313190 |
| Tacrolimus | TACROLIMUS | Strides Pharma Science Limited | ed7d1495-3585-409d-94f1-b3d2469d222c | 2025-08-05 | Boxed warning, Warnings, Adverse reactions | 313190 |
| Tacrolimus | TACROLIMUS | MylanInstitutional Inc. | 5f742224-618e-4f4c-bdec-7693be99c697 | 2025-07-22 | Boxed warning, Warnings, Adverse reactions | 313190 |
| Tacrolimus | TACROLIMUS | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd | 759cf905-7406-4d1b-a1a8-10068cb11f04 | 2025-07-11 | Boxed warning, Warnings, Adverse reactions | 313190 |
| Tacrolimus | TACROLIMUS | Quallent Pharmaceuticals Health LLC | 23b7b4d7-1431-e9f2-43ba-eabd169dc2dd | 2025-01-30 | Boxed warning, Warnings, Adverse reactions | 313190 |
| Tacrolimus | TACROLIMUS | Bryant Ranch Prepack | f21115e2-1d02-4bce-9c13-bf593a52a12f | 2025-01-08 | Boxed warning, Warnings, Adverse reactions | 313190 |
| Tacrolimus | TACROLIMUS | Panacea Biotec Limited | bd9fea26-0236-d437-c7df-4b7636210875 | 2024-12-09 | Boxed warning, Warnings, Adverse reactions | 313190 |
| Tacrolimus | TACROLIMUS | American Health Packaging | 93d03943-0655-44f6-b494-57bd1e336a34 | 2024-10-16 | Boxed warning, Warnings, Adverse reactions | 313190 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f21115e2-1d02-4bce-9c13-bf593a52a12f | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 105 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250108 |
| f21115e2-1d02-4bce-9c13-bf593a52a12f | tacrolimus 0.5 MG Oral Capsule | SCD | 105 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250108 |
| f21115e2-1d02-4bce-9c13-bf593a52a12f | tacrolimus 0.5 MG Oral Capsule | PSN | 105 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250108 |
| a2e55495-10cc-4f6e-b866-1e7d6e45888b | tacrolimus 0.5 MG Oral Capsule | SCD | 103 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250825 |
| a2e55495-10cc-4f6e-b866-1e7d6e45888b | tacrolimus 0.5 MG Oral Capsule | PSN | 103 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250825 |
| a2e55495-10cc-4f6e-b866-1e7d6e45888b | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 103 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250825 |
| 976f1b69-dd96-4815-b11b-839ce1c45633 | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 102 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20240905 |
| 976f1b69-dd96-4815-b11b-839ce1c45633 | tacrolimus 0.5 MG Oral Capsule | PSN | 102 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20240905 |
| 976f1b69-dd96-4815-b11b-839ce1c45633 | tacrolimus 0.5 MG Oral Capsule | SCD | 102 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20240905 |
| 7f667de1-9dfa-4bd6-8ba0-15ee2d78873b | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 30 | These highlights do not include all the information needed to use PROGRAF ® safely and effectively. See full prescribing information for PROGRAF. PROGRAF (tacrolimus) capsules, for oral use PROGRAF (tacrolimus) injection, for intravenous use PROGRAF Granules (tacrolimus for oral suspension) Initial U.S. Approval: 1994 | 20230825 |
| 7f667de1-9dfa-4bd6-8ba0-15ee2d78873b | tacrolimus 0.5 MG Oral Capsule | SCD | 30 | These highlights do not include all the information needed to use PROGRAF ® safely and effectively. See full prescribing information for PROGRAF. PROGRAF (tacrolimus) capsules, for oral use PROGRAF (tacrolimus) injection, for intravenous use PROGRAF Granules (tacrolimus for oral suspension) Initial U.S. Approval: 1994 | 20230825 |
| 7f667de1-9dfa-4bd6-8ba0-15ee2d78873b | tacrolimus 0.5 MG Oral Capsule | PSN | 30 | These highlights do not include all the information needed to use PROGRAF ® safely and effectively. See full prescribing information for PROGRAF. PROGRAF (tacrolimus) capsules, for oral use PROGRAF (tacrolimus) injection, for intravenous use PROGRAF Granules (tacrolimus for oral suspension) Initial U.S. Approval: 1994 | 20230825 |
| 55467f4b-8437-43a3-b6d9-1bc2a13b4c11 | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 26 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20251218 |
| 55467f4b-8437-43a3-b6d9-1bc2a13b4c11 | tacrolimus 0.5 MG Oral Capsule | SCD | 26 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20251218 |
| 55467f4b-8437-43a3-b6d9-1bc2a13b4c11 | tacrolimus 0.5 MG Oral Capsule | PSN | 26 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20251218 |
| 46ac55cf-d85e-4c34-bb33-f49e078c4a03 | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 22 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250830 |
| 46ac55cf-d85e-4c34-bb33-f49e078c4a03 | tacrolimus 0.5 MG Oral Capsule | SCD | 22 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250830 |
| 46ac55cf-d85e-4c34-bb33-f49e078c4a03 | tacrolimus 0.5 MG Oral Capsule | PSN | 22 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250830 |
| 45af3eda-caaa-4478-9372-95aa65adc9b3 | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 22 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250815 |
| 45af3eda-caaa-4478-9372-95aa65adc9b3 | tacrolimus 0.5 MG Oral Capsule | PSN | 22 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250815 |
| 45af3eda-caaa-4478-9372-95aa65adc9b3 | tacrolimus 0.5 MG Oral Capsule | SCD | 22 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250815 |
| ed7d1495-3585-409d-94f1-b3d2469d222c | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 19 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250805 |
| ed7d1495-3585-409d-94f1-b3d2469d222c | tacrolimus 0.5 MG Oral Capsule | PSN | 19 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250805 |
| ed7d1495-3585-409d-94f1-b3d2469d222c | tacrolimus 0.5 MG Oral Capsule | SCD | 19 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250805 |
| 5f742224-618e-4f4c-bdec-7693be99c697 | tacrolimus 0.5 MG Oral Capsule | SCD | 18 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250722 |
| 5f742224-618e-4f4c-bdec-7693be99c697 | tacrolimus 0.5 MG Oral Capsule | PSN | 18 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250722 |
| 5f742224-618e-4f4c-bdec-7693be99c697 | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 18 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250722 |
| 93d03943-0655-44f6-b494-57bd1e336a34 | tacrolimus 0.5 MG Oral Capsule | SCD | 18 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20241016 |
| 93d03943-0655-44f6-b494-57bd1e336a34 | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 18 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20241016 |
| 93d03943-0655-44f6-b494-57bd1e336a34 | tacrolimus 0.5 MG Oral Capsule | PSN | 18 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20241016 |
| 61dee012-43af-0e9a-3843-9b9b91e022c4 | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 16 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20231101 |
| 61dee012-43af-0e9a-3843-9b9b91e022c4 | tacrolimus 0.5 MG Oral Capsule | SCD | 16 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20231101 |
| 61dee012-43af-0e9a-3843-9b9b91e022c4 | tacrolimus 0.5 MG Oral Capsule | PSN | 16 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20231101 |
| bd9fea26-0236-d437-c7df-4b7636210875 | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 14 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES USP safely and effectively. See full prescribing information for TACROLIMUS CAPSULES USP. TACROLIMUS Capsules USP, for oral use Initial U.S. Approval: 1994 Rx only | 20241209 |
| bd9fea26-0236-d437-c7df-4b7636210875 | tacrolimus 0.5 MG Oral Capsule | PSN | 14 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES USP safely and effectively. See full prescribing information for TACROLIMUS CAPSULES USP. TACROLIMUS Capsules USP, for oral use Initial U.S. Approval: 1994 Rx only | 20241209 |
| bd9fea26-0236-d437-c7df-4b7636210875 | tacrolimus 0.5 MG Oral Capsule | SCD | 14 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES USP safely and effectively. See full prescribing information for TACROLIMUS CAPSULES USP. TACROLIMUS Capsules USP, for oral use Initial U.S. Approval: 1994 Rx only | 20241209 |
| 34ec4989-6933-4237-ae1e-50a0cb90a2fe | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 13 | TACROLIMUS capsules. These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20251211 |
| 34ec4989-6933-4237-ae1e-50a0cb90a2fe | tacrolimus 0.5 MG Oral Capsule | SCD | 13 | TACROLIMUS capsules. These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20251211 |
| 34ec4989-6933-4237-ae1e-50a0cb90a2fe | tacrolimus 0.5 MG Oral Capsule | PSN | 13 | TACROLIMUS capsules. These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20251211 |
| 3e8bc65e-8048-4073-8e45-570330603000 | tacrolimus 0.5 MG Oral Capsule | PSN | 12 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. Tacrolimus Capsules, for oral use Initial U.S. Approval: 1994 | 20260106 |
| 3e8bc65e-8048-4073-8e45-570330603000 | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 12 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. Tacrolimus Capsules, for oral use Initial U.S. Approval: 1994 | 20260106 |
| 3e8bc65e-8048-4073-8e45-570330603000 | tacrolimus 0.5 MG Oral Capsule | SCD | 12 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. Tacrolimus Capsules, for oral use Initial U.S. Approval: 1994 | 20260106 |
| 0a557ca9-b1a1-cf8f-a317-e4d8d4d6e60f | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 12 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES . TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20230928 |
| 0a557ca9-b1a1-cf8f-a317-e4d8d4d6e60f | tacrolimus 0.5 MG Oral Capsule | PSN | 12 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES . TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20230928 |
| 0a557ca9-b1a1-cf8f-a317-e4d8d4d6e60f | tacrolimus 0.5 MG Oral Capsule | SCD | 12 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES . TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20230928 |
| bf191c03-3e4b-4b45-a0d2-47809a847af6 | tacrolimus 0.5 MG Oral Capsule | PSN | 9 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20231005 |
| bf191c03-3e4b-4b45-a0d2-47809a847af6 | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 9 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20231005 |
| bf191c03-3e4b-4b45-a0d2-47809a847af6 | tacrolimus 0.5 MG Oral Capsule | SCD | 9 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20231005 |
| 4b310c6b-e035-4e44-9573-4001d58b2ad5 | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 6 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20260121 |
| 4b310c6b-e035-4e44-9573-4001d58b2ad5 | tacrolimus 0.5 MG Oral Capsule | SCD | 6 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20260121 |
| 4b310c6b-e035-4e44-9573-4001d58b2ad5 | tacrolimus 0.5 MG Oral Capsule | PSN | 6 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20260121 |
| 0addf3f5-9bd5-4ef3-8c7f-52be20c16cf9 | tacrolimus 0.5 MG Oral Capsule | PSN | 6 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250922 |
| 0addf3f5-9bd5-4ef3-8c7f-52be20c16cf9 | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 6 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250922 |
| 0addf3f5-9bd5-4ef3-8c7f-52be20c16cf9 | tacrolimus 0.5 MG Oral Capsule | SCD | 6 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250922 |
| 823b11cb-d873-4017-a861-d22d2c5a8a49 | tacrolimus 0.5 MG Oral Capsule | SCD | 5 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval:1994 | 20231110 |
| 823b11cb-d873-4017-a861-d22d2c5a8a49 | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 5 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval:1994 | 20231110 |
| 823b11cb-d873-4017-a861-d22d2c5a8a49 | tacrolimus 0.5 MG Oral Capsule | PSN | 5 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval:1994 | 20231110 |
| ca08d4aa-3de2-4a9d-9554-6288e5d36f29 | tacrolimus 0.5 MG Oral Capsule | PSN | 4 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES.TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20251229 |
| ca08d4aa-3de2-4a9d-9554-6288e5d36f29 | tacrolimus 0.5 MG Oral Capsule | SCD | 4 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES.TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20251229 |
| ca08d4aa-3de2-4a9d-9554-6288e5d36f29 | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 4 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES.TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20251229 |
| 23b7b4d7-1431-e9f2-43ba-eabd169dc2dd | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 4 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250130 |
| 23b7b4d7-1431-e9f2-43ba-eabd169dc2dd | tacrolimus 0.5 MG Oral Capsule | PSN | 4 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250130 |
| 23b7b4d7-1431-e9f2-43ba-eabd169dc2dd | tacrolimus 0.5 MG Oral Capsule | SCD | 4 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250130 |
| 393cd10e-133c-4d6b-b024-270eb82edbb3 | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 3 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20260407 |
| 393cd10e-133c-4d6b-b024-270eb82edbb3 | tacrolimus 0.5 MG Oral Capsule | PSN | 3 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20260407 |
| 393cd10e-133c-4d6b-b024-270eb82edbb3 | tacrolimus 0.5 MG Oral Capsule | SCD | 3 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20260407 |
| 875f4962-557e-4e12-ad7b-cb5fb6f2a65f | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 3 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20231211 |
| 875f4962-557e-4e12-ad7b-cb5fb6f2a65f | tacrolimus 0.5 MG Oral Capsule | PSN | 3 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20231211 |
| 875f4962-557e-4e12-ad7b-cb5fb6f2a65f | tacrolimus 0.5 MG Oral Capsule | SCD | 3 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20231211 |
| 6b89e8a4-9f11-42e3-8e79-fe617e7c461f | tacrolimus 0.5 MG Oral Capsule | SCD | 2 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval:1994 | 20260330 |
| 6b89e8a4-9f11-42e3-8e79-fe617e7c461f | tacrolimus 0.5 MG Oral Capsule | PSN | 2 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval:1994 | 20260330 |
| 6b89e8a4-9f11-42e3-8e79-fe617e7c461f | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 2 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval:1994 | 20260330 |
| 651bd506-96b0-43e5-a4dd-db03bf9154c9 | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 2 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES USP safely and effectively. See full prescribing information for TACROLIMUS CAPSULES USP. TACROLIMUS Capsule USP, for oral use Initial U.S. Approval: 1994 Rx only | 20260316 |
| 651bd506-96b0-43e5-a4dd-db03bf9154c9 | tacrolimus 0.5 MG Oral Capsule | PSN | 2 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES USP safely and effectively. See full prescribing information for TACROLIMUS CAPSULES USP. TACROLIMUS Capsule USP, for oral use Initial U.S. Approval: 1994 Rx only | 20260316 |
| 651bd506-96b0-43e5-a4dd-db03bf9154c9 | tacrolimus 0.5 MG Oral Capsule | SCD | 2 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES USP safely and effectively. See full prescribing information for TACROLIMUS CAPSULES USP. TACROLIMUS Capsule USP, for oral use Initial U.S. Approval: 1994 Rx only | 20260316 |
| 759cf905-7406-4d1b-a1a8-10068cb11f04 | tacrolimus 0.5 MG Oral Capsule | PSN | 1 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250711 |
| 759cf905-7406-4d1b-a1a8-10068cb11f04 | tacrolimus 0.5 MG (as anhydrous tacrolimus) Oral Capsule | SY | 1 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250711 |
| 759cf905-7406-4d1b-a1a8-10068cb11f04 | tacrolimus 0.5 MG Oral Capsule | SCD | 1 | These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral use Initial U.S. Approval: 1994 | 20250711 |